Google tightened the "Good" LCP threshold from 2.5 to 2.0 seconds in March 2026, and promoted INP from supplementary to a ...

The pace of D.C. restaurant closings has slowed significantly this year, but a key industry group warns it could be the calm ...

Almost every framework I evaluated assumed agents needed to perceive the web the way humans do, visually, pixel by pixel. The ...

KS1 Science / Geography. This short video for primary age children explores the relationship of the Earth to the sun, the cause of the seasons. Suitable for teaching science and geography at KS1 and ...

Claims-based ATTR-CM incidence increased >4-fold in Medicare (2010–2021) and ~2.7-fold in commercial insurance (2016–2022), with parallel multi-fold prevalence increases across databases. Higher rates ...

ATTR-cardiac amyloidosis (ATTR-CM) is a progressive heart condition often mistaken for normal aging. For years, communication in the category has focused on urgency and decline, leaving patients with ...

BridgeBio Pharma is teaming up with BlackDoctor and HealthyWomen to highlight how the heart condition ATTR-cardiac amyloidosis (ATTR-CM) is being “systematically missed in women.” The condition is a ...

Diagnosing ATTR-CM early allows clinicians to initiate treatment before substantial amyloid deposits accumulate in the myocardium. The lack of specificity in the clinical presentation of transthyretin ...

A retrospective MarketScan commercial and Medicare supplemental cohort (2018–2022) identified 505 tafamidis users, using Vyndamax claims as a surrogate marker for confirmed ATTR-CM. Diagnostic delay ...

In ATTR amyloidosis, a buildup of harmful proteins causes damage to tissues and organs throughout the body, including the heart. Over time, the condition can progress from stage 1, which may cause ...

Genetic testing is an important part of the diagnosis process for transthyretin cardiac amyloidosis (ATTR-CM). It’s not only key to managing your care but also helps you determine whether others in ...

The model had an area under the receiver operating characteristic curve of 0.83 in a high-risk subgroup of patients with conditions that mimic ATTR-CM. An artificial intelligence model trained to ...